Non-invasive venous waveform analysis (NIVA) for volume assessment in patients undergoing hemodialysis: an observational study.


Journal

BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793

Informations de publication

Date de publication:
24 05 2020
Historique:
received: 24 04 2019
accepted: 08 05 2020
entrez: 26 5 2020
pubmed: 26 5 2020
medline: 2 9 2021
Statut: epublish

Résumé

Accurate assessment of volume status to direct dialysis remains a clinical challenge. Despite current attempts at volume-directed dialysis, inadequate dialysis and intradialytic hypotension (IDH) are common occurrences. Peripheral venous waveform analysis has recently been developed as a method to accurately determine intravascular volume status through algorithmic quantification of changes in the waveform that occur at different volume states. A noninvasive method to capture peripheral venous signals is described (Non-Invasive Venous waveform Analysis, NIVA). The objective of this proof-of-concept study was to characterize changes in NIVA signal with dialysis. We hypothesized that there would be a change in signal after dialysis and that the rate of intradialytic change in signal would be predictive of IDH. Fifty subjects undergoing inpatient hemodialysis were enrolled. A 10-mm piezoelectric sensor was secured to the middle volar aspect of the wrist on the extremity opposite to the access site. Signals were obtained fifteen minutes before, throughout, and up to fifteen minutes after hemodialysis. Waveforms were analyzed after a fast Fourier transformation and identification of the frequencies corresponding to the cardiac rate, with a NIVA value generated based on the weighted powers of these frequencies. Adequate quality (signal to noise ratio > 20) signals pre- and post- dialysis were obtained in 38 patients (76%). NIVA values were significantly lower at the end of dialysis compared to pre-dialysis levels (1.203 vs 0.868, p < 0.05, n = 38). Only 16 patients had adequate signals for analysis throughout dialysis, but in this small cohort the rate of change in NIVA value was predictive of IDH with a sensitivity of 80% and specificity of 100%. This observational, proof-of-concept study using a NIVA prototype device suggests that NIVA represents a novel and non-invasive technique that with further development and improvements in signal quality may provide static and continuous measures of volume status to assist with volume directed dialysis and prevent intradialytic hypotension.

Sections du résumé

BACKGROUND
Accurate assessment of volume status to direct dialysis remains a clinical challenge. Despite current attempts at volume-directed dialysis, inadequate dialysis and intradialytic hypotension (IDH) are common occurrences. Peripheral venous waveform analysis has recently been developed as a method to accurately determine intravascular volume status through algorithmic quantification of changes in the waveform that occur at different volume states. A noninvasive method to capture peripheral venous signals is described (Non-Invasive Venous waveform Analysis, NIVA). The objective of this proof-of-concept study was to characterize changes in NIVA signal with dialysis. We hypothesized that there would be a change in signal after dialysis and that the rate of intradialytic change in signal would be predictive of IDH.
METHODS
Fifty subjects undergoing inpatient hemodialysis were enrolled. A 10-mm piezoelectric sensor was secured to the middle volar aspect of the wrist on the extremity opposite to the access site. Signals were obtained fifteen minutes before, throughout, and up to fifteen minutes after hemodialysis. Waveforms were analyzed after a fast Fourier transformation and identification of the frequencies corresponding to the cardiac rate, with a NIVA value generated based on the weighted powers of these frequencies.
RESULTS
Adequate quality (signal to noise ratio > 20) signals pre- and post- dialysis were obtained in 38 patients (76%). NIVA values were significantly lower at the end of dialysis compared to pre-dialysis levels (1.203 vs 0.868, p < 0.05, n = 38). Only 16 patients had adequate signals for analysis throughout dialysis, but in this small cohort the rate of change in NIVA value was predictive of IDH with a sensitivity of 80% and specificity of 100%.
CONCLUSIONS
This observational, proof-of-concept study using a NIVA prototype device suggests that NIVA represents a novel and non-invasive technique that with further development and improvements in signal quality may provide static and continuous measures of volume status to assist with volume directed dialysis and prevent intradialytic hypotension.

Identifiants

pubmed: 32448178
doi: 10.1186/s12882-020-01845-2
pii: 10.1186/s12882-020-01845-2
pmc: PMC7245891
doi:

Types de publication

Journal Article Observational Study Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

194

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : National Science Foundation
ID : 1549576
Pays : International

Références

Hypertension. 1999 Oct;34(4 Pt 2):808-12
pubmed: 10523365
Shock. 2016 Oct;46(4):447-52
pubmed: 27070329
Jpn Circ J. 1989 Mar;53(3):245-54
pubmed: 2545936
Front Surg. 2017 Feb 09;4:6
pubmed: 28232909
Kidney Int. 2004 Sep;66(3):1212-20
pubmed: 15327420
J Card Fail. 2018 Aug;24(8):525-532
pubmed: 29777760
J Appl Physiol (1985). 1993 Feb;74(2):499-509
pubmed: 8458763
Artif Organs. 2003 Mar;27(3):227-9
pubmed: 12662207
Nephrol Dial Transplant. 2003 Dec;18(12):2601-5
pubmed: 14605284
Semin Dial. 2017 Nov;30(6):473-480
pubmed: 28661565
IEEE Rev Biomed Eng. 2012;5:45-59
pubmed: 23231988
J Card Fail. 2020 Feb;26(2):136-141
pubmed: 31574315
Ann Biomed Eng. 2015 Jun;43(6):1443-60
pubmed: 25832485
J Am Soc Nephrol. 2011 Aug;22(8):1526-33
pubmed: 21803971
Circ Res. 1960 Sep;8:1059-76
pubmed: 13687404
Br J Anaesth. 2017 Dec 1;119(6):1135-1140
pubmed: 29028929
J Clin Anesth. 2020 May;61:109664
pubmed: 31786067
Semin Dial. 2012 Sep-Oct;25(5):592-5
pubmed: 22452638
Biomed Res Int. 2018 Feb 27;2018:8276912
pubmed: 29682559
Nephrol Dial Transplant. 2009 Feb;24(2):604-10
pubmed: 18775808
Clin J Am Soc Nephrol. 2008 Jan;3(1):19-26
pubmed: 18003765
Intensive Care Med. 2015 Jun;41(6):1147-8
pubmed: 25862041
Curr Opin Anaesthesiol. 2009 Dec;22(6):814-21
pubmed: 19844178

Auteurs

Bret D Alvis (BD)

Department of Anesthesiology, Division of Critical Care, Vanderbilt University Medical Center, 422 MAB, 1211 21st Ave South, Nashville, TN, 37212, USA.

Monica Polcz (M)

Vanderbilt University Medical Center, S111 Medical Center North, 21st Ave South, Medical Art Building 422, Nashville, TN, 37212, USA. monica.polcz@vumc.org.

Merrick Miles (M)

Department of Anesthesiology, Division of Critical Care, Vanderbilt University Medical Center, 422 MAB, 1211 21st Ave South, Nashville, TN, 37212, USA.

Donald Wright (D)

Vanderbilt University School of Medicine, 1161 21st Ave S # D3300, Nashville, TN, 37232, USA.

Mohammad Shwetar (M)

Vanderbilt University School of Medicine, 1161 21st Ave S # D3300, Nashville, TN, 37232, USA.

Phil Leisy (P)

Department of Anesthesiology, Division of Critical Care, Vanderbilt University Medical Center, 422 MAB, 1211 21st Ave South, Nashville, TN, 37212, USA.

Rachel Forbes (R)

Department of Surgery, Division of Kidney and Pancreas Transplantation, Vanderbilt University Medical Center, 1301 Medical Center Drive, Nashville, TN, 37232, USA.

Rachel Fissell (R)

Department of Medicine, Division of Nephrology and Hypertension, Vanderbilt University Medical Center, 1161 21st Ave South, MCN S-3223, Nashville, TN, 37232, USA.

Jon Whitfield (J)

Volumetrix, LLC, 2126 21st Ave South, Nashville, TN, 37212, USA.

Susan Eagle (S)

Vanderbilt University Medical Center, S111 Medical Center North, 21st Ave South, Medical Art Building 422, Nashville, TN, 37212, USA.

Colleen Brophy (C)

Vanderbilt University Medical Center, S111 Medical Center North, 21st Ave South, Medical Art Building 422, Nashville, TN, 37212, USA.

Kyle Hocking (K)

Vanderbilt University Medical Center, S111 Medical Center North, 21st Ave South, Medical Art Building 422, Nashville, TN, 37212, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH